Nyt fra tidsskrifterne
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
37 ud af 37 tidsskrifter valgt, ingen søgeord valgt, emner højest 7 dage gamle, sorteret efter nyeste først.
166 emner vises.
Trusha Nana, Olga Perovic, Vindana Chibabhai
Clinical Microbiology and Infection, 6.07.2022
Tilføjet 7.07.2022
The aim of this laboratory-based study was to compare carbapenem minimum inhibitory concentrations (MICs) yielded by Sensititre, Vitek 2, MicroScan WalkAway plus and Etest for OXA-48-like Klebsiella pneumoniae isolates.
Læs mere Tjek på PubMedStephen R. Doyle
Trends in Parasitology, 6.07.2022
Tilføjet 7.07.2022
Rapid advancement in high-throughput sequencing and analytical approaches has seen a steady increase in the generation of genomic resources for helminth parasites. Now, helminth genomes and their annotations are a cornerstone of numerous efforts to compare genetic and transcriptomic variation, from single cells to populations of globally distributed parasites, to genome modifications to understand gene function. Our understanding of helminths is increasingly reliant on these genomic resources, which are primarily static once published and vary widely in quality and completeness between species.
Læs mere Tjek på PubMedHannah Charles, Mateo Prochazka, Katie Thorley, Adam Crewdson, David R Greig, Claire Jenkins, Anais Painset, Helen Fifer, Lynda Browning, Paul Cabrey, Robert Smith, Daniel Richardson, Laura Waters, Katy Sinka, Gauri Godbole, Outbreak Control Team
Lancet Infectious Diseases, 7.07.2022
Tilføjet 7.07.2022
We highlight the rapid dissemination of XDR ESBL-producing S sonnei in sexual networks of MSM. We recommend strengthening shigella testing where clinically indicated, antimicrobial-resistance surveillance, and integrated health promotion messaging among all MSM, including PrEP users, to reduce the burden of shigellosis.
Læs mere Tjek på PubMedMarcus Y Chen, Deborah A Williamson
Lancet Infectious Diseases, 7.07.2022
Tilføjet 7.07.2022
Over the past decade, we have seen major international outbreaks of viruses and bacteria—that are usually transmitted through non-sexual person-to-person contact—resulting from sexual transmission and spread through sexual networks. This includes the global dissemination of hepatitis A and antimicrobial-resistant Shigella among men who have sex with men.1 These outbreaks have occurred against a backdrop of sustained transmission and increasing prevalence of established sexually transmitted infections such as syphilis and gonorrhoea in many countries, which have resulted in widespread morbidity.
Læs mere Tjek på PubMedChristopher Chew, Nikhilesh Thapa, Henry Ogbuagu, Merin Varghese, Dhaval Patel, Raza Abbas, Jason Oh, Molla Teshome, Khaja Mohammed, Sohail Saleem, Deepak Aggarwal, Barry Barns, April McDonald, Claudia Ormenisan-Gherasim
Lancet Infectious Diseases, 7.07.2022
Tilføjet 7.07.2022
Pulmonary blastomycosis is a respiratory disease that is caused by the fungus Blastomyces spp, which is acquired through inhalation of the fungal spores. Blastomycosis is relatively uncommon, with yearly incidence rate of 1–2 cases per 100 000 people. Blastomycosis is a disease that is endemic to the midwest and southern regions of the USA, most commonly affecting immunocompromised patients. About 50% of patients are asymptomatic, but for those who progress to acute respiratory distress syndrome (ARDS) mortality can be as high as 80%.
Læs mere Tjek på PubMedGaspard Mande, Innocent Akonda, Anja De Weggheleire, Isabel Brosius, Laurens Liesenborghs, Emmanuel Bottieau, Noam Ross, Guy -Crispin Gembu, Robert Colebunders, Erik Verheyen, Ngonda Dauly, Herwig Leirs, Anne Laudisoit
International Journal of Infectious Diseases, 6.07.2022
Tilføjet 7.07.2022
: Following an outbreak of cases of vesicular-pustular rash with fever evocative of human monkeypox in Bas-Uélé province, Democratic Republic of Congo, surveillance was strengthened.
Læs mere Tjek på PubMedGabriela Abelenda-Alonso, Alexander Rombauts, Carlota Gudiol, Esther García-Lerma, Natalia Pallarés, Carmen Ardanuy, Laura Calatayud, Jordi Niubó, Cristian Tebé, Jordi Carratalà
Clinical Microbiology and Infection, 6.07.2022
Tilføjet 7.07.2022
The usefulness of routine microbiological testing for rationalizing antibiotic use in hospitalized patients with community-acquired pneumonia (CAP) continues to be a subject of debate. We aim to determine the effect of positive microbiological testing on antimicrobial de-escalation and clinical outcomes in CAP.
Læs mere Tjek på PubMedAndrea Du Toit
Nat Rev Microbiol, 6.07.2022
Tilføjet 6.07.2022
Nature Reviews Microbiology, Published online: 06 July 2022; doi:10.1038/s41579-022-00771-4This study shows that flaviviruses promote the proliferation of acetophenone-producing skin commensal bacteria, which enhances mosquito attraction and thus flavivirus transmission.
Læs mere Tjek på PubMedJerry Joe E. K. Harrison, Dario Oliveira Passos, Jessica F. Bruhn, Joseph D. Bauman, Lynda Tuberty, Jeffrey J. DeStefano, Francesc Xavier Ruiz, Dmitry Lyumkis, Eddy Arnold
Science Advances, 6.07.2022
Tilføjet 6.07.2022
Jacob McPherson, Chenlin Hu, Khurshida Begum, Weiqun Wang, Chris Lancaster, Anne J. Gonzales-Luna, Caroline Loveall, Michael H. Silverman, M. Jahangir Alam, Kevin W. Garey aUniversity of Houstongrid.266436.3 College of Pharmacy, Houston, Texas, USA bAcurx Pharmaceuticals, Staten Island, New York, USA
Antimicrobial Agents And Chemotherapy, 6.07.2022
Tilføjet 6.07.2022
Elangwe M. Sarah-Matio, Emilie Guillochon, Sandrine E. Nsango, Luc Abate, Christelle M. Ngou, Gaelle A. Bouopda, Lionel B. Feufack-Donfack, Albert N. Bayibéki, Majoline Tchioffo Tsapi, Arthur Talman, Alejandro Marin-Menendez, Lawrence Ayong, Antoine Claessens, Thierry Lefèvre, Antoine Berry, Isabelle Morlais aMIVEGEC, Université de Montpellier, CNRS, IRD, Montpellier, France bMalaria Research Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon cUniversité de Paris, MERIT, IRD, Paris, France dDepartment of Biological Sciences, Faculté de Médecine et des Sciences Pharmaceutiques, Université de Douala, Douala, Cameroon eUniversité Catholique d’Afrique Centrale, Yaoundé, Cameroon fLPHI, Université de Montpellier, INSERM, CNRS, Montpellier, France gInstitut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse, CNRS UMR5051, INSERM UMR1291, UPS, Toulouse, France hService de Parasitologie_Mycologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
Antimicrobial Agents And Chemotherapy, 6.07.2022
Tilføjet 6.07.2022
Nilesh Kumta, Aaron J. Heffernan, Menino Osbert Cotta, Steven C. Wallis, Amelia Livermore, Therese Starr, Wai Tat Wong, Gavin M. Joynt, Jeffrey Lipman, Jason A. Roberts aUniversity of Queenslandgrid.1003.2 Centre for Clinical Research, Faculty of Medicine, University of Queensland, Herston, Brisbane, Queensland, Australia bSchool of Medicine, Griffith University, Southport, Queensland, Australia cDepartment of Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Herston, Brisbane, Queensland, Australia dDepartment of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong SAR, China eJamieson Trauma Institute, Royal Brisbane and Women’s Hospital, Herston, Brisbane, Queensland, Australia fDivision of Anaesthesiology, Critical Care Emergency and Pain Medicine, Nimes University Hospital, University of Montpellier, Nimes, France gPharmacy Department, Royal Brisbane and Women’s Hospital, Herston, Brisbane, Queensland, Australia
Antimicrobial Agents And Chemotherapy, 6.07.2022
Tilføjet 6.07.2022
Nitasha D. Menon, Samuel Penziner, Elizabeth T. Montaño, Raymond Zurich, David T. Pride, Bipin G. Nair, Geetha B. Kumar, Victor Nizet aSchool of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Kerala, India bDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, California, USA cDivision of Infectious Diseases and Global Public Health, Department of Medicine, UC San Diego, La Jolla, California, USA dDepartment of Pathology, UC San Diego, La Jolla, California, USA eTata Institute for Genetics and Society (TIGS), Bangalore, Karnataka, India fSkaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla, California, USA
Antimicrobial Agents And Chemotherapy, 6.07.2022
Tilføjet 6.07.2022
Isaac O. Onkanga, Rachael Hamilton, Pauline N. M. Mwinzi, Thomas Schneider, Bartholomew N. Ondigo, Huldah Sang, Edna Ondari, Fredrick Rawago, Walter Jaoko, Maurice R. Odiere, Lisa Ganley-Leal aCenter for Global Health Research, Kenya Medical Research Institutegrid.33058.3d, Kisumu, Kenya bKAVI-Institute of Clinical Research, and Department of Medical Microbiology & Immunology, University of Nairobigrid.10604.33, Kenya cElegance Biotechnologies, LLC, Wayne, Pennsylvania, USA dDepartment of Biochemistry and Molecular Biology, Egerton University, Nakuru, Kenya, Guy H. Palmer
Infection and Immunity, 6.07.2022
Tilføjet 6.07.2022
Steve Van den Bulck, Jonas Crèvecoeur, Bert Aertgeerts, Nicolas Delvaux, Thomas Neyens, Gijs Van Pottelbergh, Patrick Coursier, Bert Vaes
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Steve Van den Bulck, Jonas Crèvecoeur, Bert Aertgeerts, Nicolas Delvaux, Thomas Neyens, Gijs Van Pottelbergh, Patrick Coursier, Bert Vaes
Introduction The Covid-19 pandemic had a tremendous impact on healthcare but uncertainty remains about the extent to which primary care provision was affected. Therefore, this paper aims to assess the impact on primary care provision and the evolution of the incidence of disease during the first year of the Covid-19 pandemic in Flanders (Belgium). Methods Care provision was defined as the number of new entries added to a patient’s medical history. Pre-pandemic care provision (February 1, 2018–January 31, 2020) was compared with care provision during the pandemic (February 1, 2020-January 31, 2021). A large morbidity registry (Intego) was used. Regression models compared the effect of demographic characteristics on care provision and on acute and chronic diagnoses incidence both prior and during the pandemic. Results During the first year of the Covid-19 pandemic, overall care provision increased with 9.1% (95%CI 8.5%;9.6%). There was an increase in acute diagnoses of 5.1% (95%CI 4.2%;6.0%) and a decrease in the selected chronic diagnoses of 12.8% (95% CI 7.0%;18.4%). Obesity was an exception with an overall incidence increase. The pandemic led to strong fluctuations in care provision that were not the same for all types of care and all demographic groups in Flanders. Relative to other groups in the population, the pandemic caused a reduction in care provision for children aged 0–17 year and patients from a lower socio-economic situation. Conclusion This paper strengthened the claim that Covid-19 should be considered as a syndemic instead of a pandemic. During the first Covid-19 year, overall care provision and the incidence of acute diagnoses increased, whereas chronic diseases’ incidence decreased, except for obesity diagnoses which increased. More granular, care provision and chronic diseases’ incidence decreased during the lockdowns, especially for people with a lower socio-economic status. After the lockdowns they both returned to baseline.
Læs mere Tjek på PubMedAdeoye John Kayode, Anthony Ifeanyi Okoh
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Adeoye John Kayode, Anthony Ifeanyi Okoh
The occurrence and the antibiogram signatures of Listeria monocytogenes (Lm) recovered from 65 milk samples and its products within the Eastern Cape province were examined. The EN ISO 11290:2017 procedures Parts 1 and 2 described by the International Organization for Standardization for the enumeration and isolation of Lm was adopted for the study. Lm was detected in 18.46% of all the samples examined, and the strains recovered from the samples belong to serotypes 4b and 1/2b. The virulence determinants including prfA, plcA, plcB, inlA, inlC, hly, mpl, actA, inlJ and inlB were detected in all the isolates. About 95.24% of the studied Lm isolates demonstrated potential capacity for biofilm formation. The antibiogram profile revealed high resistance against sulfamethoxazole (71.43%), trimethoprim (52.86%); erythromycin, cefotetan and oxytetracycline (42.86% respectively). About 85.71% exhibited multiple antibiotic resistance phenotypes against the test antibiotics. The resistance determinants encoding resistance against the β-lactamase antibiotics [such as the blaTEM, blaSHV, blaTEM variants (TEM-1 and TEM-2) and the blaZ], the tetracycline resistance genes (including tetA, tetD, tetG and tetM and tetK) were detected among resistant isolates. In addition, the aminoglycoside resistance gene aph (3)-IIa (aphA2)a was detected only in one isolate. Finally, the sulfonamide resistance genes including the sul2 and the sul1 genes were the most frequently observed among Lm isolates. Generally, 71.43% of all Lm isolates recovered from the samples investigated harboured one or more resistance genes encoding resistance against various antibiotics. The antibiogram signatures of Lm isolates observed in this study is an indication that empirical treatment of listeriosis may be challenging in the future as the pathogen may obliterate the success of antibiotics. We, therefore, advocate for the recognition of the One Health approach to ensuring food safety and curbing the spread of antimicrobial resistance in food.
Læs mere Tjek på PubMedFrank Baiden, Suzanne Fleck, Bailah Leigh, Philip Ayieko, Daniel Tindanbil, Tuda Otieno, Bolarinde Lawal, Mattu Tehtor, Maariam Rogers, Lazarus Odeny, Mary H. Hodges, Mustapha Sonnie, Mohamed Samai, David Ishola, Brett Lowe, Deborah Watson-Jones, Brian Greenwood
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Frank Baiden, Suzanne Fleck, Bailah Leigh, Philip Ayieko, Daniel Tindanbil, Tuda Otieno, Bolarinde Lawal, Mattu Tehtor, Maariam Rogers, Lazarus Odeny, Mary H. Hodges, Mustapha Sonnie, Mohamed Samai, David Ishola, Brett Lowe, Deborah Watson-Jones, Brian Greenwood
Introduction Recurrent parasitic infections may influence the immune response to vaccines. In the Partnership for Research on Ebola VACcinations extended follow-UP and clinical research capacity build-UP (PREVAC-UP) study being undertaken in Mambolo, northern Sierra Leone, participants are being followed up to assess the potential impact of exposure to malaria and/or helminth infections on long-term immune response to two Ebola vaccines. To support the development of the assays that will be used in this evaluation, a parasitological survey was conducted in Mambolo between November 2019 and February 2020. Methods Healthy individuals aged ≥1 year who were resident in Mambolo Chiefdom were selected using a stratified sampling approach and questionnaires were administered to explore their sociodemographic characteristics. Microscopy was used to detect malaria parasites, intestinal helminths and urinary schistosome infections. Rapid blood tests were used to detect infections with Onchocerca volvulus and Wuchereria bancrofti. We estimated the overall prevalence of these infections and used adjusted logistic regression models to explore risk factors for malaria and hookworm infection. Results Eight hundred and fifteen (815) residents, 50.9% of whom were female were surveyed. Overall, 309 (39.1%) of 791 persons tested for malaria had a positive blood slide; Plasmodium falciparum was the dominant species. Helminth infection was detected in 122 (15.0%) of 815 stool samples including three mixed infections. The helminth infections comprised 102 (12.5%) cases of hookworm, 11 (1.3%) cases of Trichuris trichiura, 10 (1.2%) cases of Schistosoma mansoni and two (0.2%) cases of Ascaris lumbricoides. Being male (OR = 2.01, 95% CI 1.15–3.50) and residing in a non-riverine community (OR = 4.02, 95%CI 2.32–6.98) were the factors associated with hookworm infection. Onchocerca volvulus and Wuchereria bancrofti infections were found in 3.3% and 0.4% of participants respectively. Conclusion Malaria and hookworm are the most prevalent parasite infections and those most likely to influence long-term immune response to Ebola vaccines among the trial participants.
Læs mere Tjek på PubMedCláudio Manuel Rodrigues, Francisco Dourado, Daniel Savignon Marinho, Gilberto Salles Gazêta, Lena Geise
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Cláudio Manuel Rodrigues, Francisco Dourado, Daniel Savignon Marinho, Gilberto Salles Gazêta, Lena Geise
Spotted fever rickettsiosis is a zoonosis transmitted by ticks, having a varied clinical course that can lead to death if not managed properly. In Brazil it is more commonly observed in the Southeast, being an emerging public health problem. Hazard mapping models are common in different areas of knowledge, including public health, as a way of inferring reality and seeking to reduce or prevent damage. The aim of this study is to offer a spatial heuristic methodology for assessing the potential risk of transmission of spotted fever in the Rio de Janeiro state, located in the southeastern region of Brazil. For this, we used geospatial tools associated with eco-epidemiological data related to the clinical profile of the disease. The results achieved were substantially encouraging, considering that there are territories with greater or lesser expectation of risk for spotted fever in the study area. We observed that there are important distinctions between the two rickettsiosis scenarios in the same geographic space and that the areas where there is a greater potential risk of contracting rickettsiosis coincide with the administrative regions that concentrated the cases of hospitalization and deaths from the disease, concluding that the scenery found are relevant to the case series for the disease and that the planning of surveillance actions can gain in quality if the use of this spatial analysis tool is incorporated into the routine of local health management.
Læs mere Tjek på PubMedSebastian Rauch, Louisa Arnold, Zelda Stuerner, Juergen Rauh, Michael Rost
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Sebastian Rauch, Louisa Arnold, Zelda Stuerner, Juergen Rauh, Michael Rost
While the place of birth plays a crucial role for women’s birth experiences, the interest in out-of-hospital births has increased during the Covid-19 pandemic. Related to this, various international policies recommend enabling women to choose where to give birth. We aimed to analyze Swiss women’s choice between birth hospitals and birth centers. Employing spatial accessibility analysis, we incorporated four data types: highly disaggregated population data, administrative data, street network data, addresses of birth hospitals and birth centers. 99.8% of Swiss women of childbearing age were included in the analysis (N = 1.896.669). We modelled car travel times from a woman’s residence to the nearest birth hospital and birth center. If both birth settings were available within 30 minutes, a woman was considered to have a true choice. Only 58.2% of women had a true choice. This proportion varied considerably across Swiss federal states. The main barrier to a true choice was limited accessibility of birth centers. Median travel time to birth hospitals was 9.8 (M = 12.5), to birth centers 23.9 minutes (M = 28.5). Swiss women are insufficiently empowered to exercise their reproductive autonomy as their choice of place of birth is significantly limited by geographical constraints. It is an ethical and medical imperative to provide women with a true choice. We provide high-resolution insights into the accessibility of birth settings and strong arguments to (re-)examine the need for further birth centers (and birth hospitals) in specific geographical areas. Policy-makers are obligated to improve the accessibility of birth centers to advance women’s autonomy and enhance maternal health outcomes after childbirth. The Covid-19 pandemic offers an opportunity to shift policy.
Læs mere Tjek på PubMedAmira Jamoussi, Samia Ayed, Takoua Merhabene, Hamdi Doghri, Jalila Ben Khelil, Mohamed Besbes
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Amira Jamoussi, Samia Ayed, Takoua Merhabene, Hamdi Doghri, Jalila Ben Khelil, Mohamed Besbes
Introduction Influenza A virus infection is a contagious acute respiratory infection which mostly evolves in an epidemic form, less frequently as pandemic outbreaks. It can take a severe clinical form that needs to be managed in intensive care unit (ICU). The aim of this study was to describe the epidemiological and clinical aspects of influenza A, then to determine independent predictive factors of ICU mortality in Abderrahmen Mami hospital, Ariana, Tunisia. Methods It was a single-center study, including all hospitalized patients in intensive care, between November 1st, 2009 and October 31st, 2019, with influenza A virus infection. We recorded demographic, clinical and biological data, evolving features; then multivariate analysis of the predictive factors of ICU mortality was realized. Results During the study period (10 consecutive seasons), 120 patients having severe Influenza A were admitted (Proportion = 2.5%) from all hospitalized patients, with a median age of 48 years and a gender-ratio of 1.14. Among women, 14 were pregnant. Only 7 patients (5.8%) have had seasonal flu vaccine during the year before ICU admission. The median values of the Simplified Acute Physiology Score II, Acute Physiologic and Chronic Health Evaluation II and Sepsis-related Organ Failure Assessment were respectively 26, 10 and 3. Virus strains identified with polymerase chain reaction were H1N1 pdm09 (84.2%) and H3N2 (15.8%). Antiviral therapy was prescribed in 88 (73.3%) patients. A co-infection was recorded in 19 cases: bacterial (n = 17) and aspergillaire (n = 2). An acute respiratory distress syndrome (ARDS) was diagnosed in 82 patients. Non-invasive ventilation (NIV) was conducted for 72 (60%) patients with success in 34 cases. Endotracheal intubation was performed in 59 patients with median duration of invasive mechanical ventilation 8 [3.25–13] days. The most frequent complications were acute kidney injury (n = 50, 41.7%), shock (n = 48, 40%), hospital-acquired infections (n = 46, 38.8%) and thromboembolic events (n = 19, 15.8%). The overall ICU mortality rate was of 31.7% (deceased n = 38). Independent predictive factors of ICU mortality identified were: age above 56 years (OR = 7.417; IC95% [1.474–37.317]; p = 0.015), PaO2/FiO2 ≤ 95 mmHg (OR = 9.078; IC95% [1.636–50.363]; p = 0.012) and lymphocytes count ≤ 1.325 109/L (OR = 10.199; IC95% [1.550–67.101]; p = 0.016). Conclusion Influenza A in ICU is not uncommon, even in A(H1N1) dominant seasons; its management is highly demanding. It is responsible for considerable morbi-mortality especially in elderly patients.
Læs mere Tjek på PubMedIzumi Yamatani, Kosaku Komiya, Hisayuki Shuto, Marimu Yamanaka, Mari Yamasue, Hiroki Yoshikawa, Kazufumi Hiramatsu, Jun-ichi Kadota
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Izumi Yamatani, Kosaku Komiya, Hisayuki Shuto, Marimu Yamanaka, Mari Yamasue, Hiroki Yoshikawa, Kazufumi Hiramatsu, Jun-ichi Kadota
Background Although persistent tuberculosis (TB) infection is known to cause calcification in the lungs, the relationship between intrathoracic calcification and the results of the interferon-γ release assay (IGRA) has not been fully elucidated. This study aimed to assess the association between intrathoracic calcification and IGRA results. Methods We retrospectively included consecutive patients who concurrently underwent chest X-ray, chest computed tomography (CT), and an IGRA. Patients with a current diagnosis of active TB or treatment history of active TB or latent tuberculosis infection (LTBI) were excluded. The association between calcification according to the chest X-ray or CT and IGRA results were analyzed using binomial logistic regression. Results This study included 574 patients, and 38 (7%) patients had a positive IGRA result. Patients with a positive result were significantly older and had a higher proportion of comorbidities, and history of tuberculosis exposure compared to those with a negative result. Calcification of the lung field and mediastinal lymph nodes according to chest CT was more frequently observed in patients with a positive IGRA result, whereas no significant difference was observed concerning the proportion of lung field calcification on chest X-ray between patients with positive and negative IGRA results. In multivariate analysis, calcification of mediastinal lymph nodes alone (adjusted odds ratio [OR] = 3.82, 95% confidence interval [CI] = 1.76–8.26) and the combination of lung field and mediastinal lymph node calcification (adjusted OR = 4.12, 95% CI = 1.51–11.76) on chest CT was independently associated with positive IGRA results. Conclusions The finding of mediastinal lymph node calcification, with or without lung field calcification, on chest CT was associated with positive IGRA results independent of TB exposure history. Previous TB infection including eliminated TB infection and LTBI can be suspected when calcified lymph nodes in are observed the mediastinum on chest CT.
Læs mere Tjek på PubMedAli Qureshi, Syed Azhar Syed Sulaiman, Narendar Kumar, Pir Abdul Ahad Aziz Qureshi
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Ali Qureshi, Syed Azhar Syed Sulaiman, Narendar Kumar, Pir Abdul Ahad Aziz Qureshi
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-1), notoriously known as COVID-19, emerged in 2019 and was responsible for causing acute respiratory collapse. Moreover, in September 2020, new variant cases of severe acute respiratory syndrome coronavirus 2 were reported in the United Kingdom, with many patients and deaths. This study aimed to see knowledge, perception, and fear among the global population towards a new variant of severe acute respiratory syndrome coronavirus 2, known as Omicron (B.1.1.529). This online cross-sectional global study was conducted during the emergence of the B.1.1.529 variant, also known as the Omicron variant. The survey was carried out from 2nd December 2021 to 3rd January 2022. The descriptive analysis was presented as frequencies (N), percentages (%), and mean ± standard deviation (m ± SD). The association between dependent and categorical independent variables was determined using the Chi-square test (x2). Statistical analysis was performed by using SPSS version 23. Of 353 respondents, approximately 61% were females. One hundred fifty-four respondents were in the age group of 18–27 years. The average age was 31.53±10.3 (mean± SD). The majority of respondents (43.9%) were from Indonesia. The mean knowledge score about the Omicron variant was 3.18±1.14. Our study suggests that people have some knowledge about the new variant, Omicron (B.1.1.529). Besides, there was a significant association (p = 0.05) for the perception of the fatality rate of Omicron among the respondents from different countries. However, there is still an ample research gap in enlightening people about this infection (B.1.1.529).
Læs mere Tjek på PubMedVipin Kumar, Ayushi Mishra, Awadehesh Kumar Yadav, Sushma Rathaur, Anchal Singh
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Vipin Kumar, Ayushi Mishra, Awadehesh Kumar Yadav, Sushma Rathaur, Anchal Singh
Lymphatic Filariasis (LF) affects more than 863 million people in tropical and subtropical areas of the world, causing high morbidity and long illnesses leading to social exclusion and loss of wages. A combination of drugs Ivermectin, Diethylcarbamazine citrate and Albendazole is recommended by WHO to accelerate the Global Programme to Eliminate Lymphatic Filariasis (GPELF). To assess the outcome of GPELF, to re-evaluate and to formulate further strategies there is an imperative need for high quality diagnostic markers. This study was undertaken to identify Lymphatic Filarial biomarkers which can detect LF infections in asymptomatic cases and would also serve as indicators for differentiating among different clinical stages of the disease. A combination of Fourier-transform infrared spectroscopy (FT-IR), MMP zymography, SDS-PAGE, classical 2DE along with MALDI-TOF/MS was done to identify LF biomarkers from serum samples of different stages of LF patients. FT-IR spectroscopy coupled with univariate and multivariate analysis of LF serum samples, revealed significant differences in peak intensity at 3300, 2950, 1645, 1540 and 1448 cm-1 (p<0.05). The proteomics analysis results showed that various proteins were differentially expressed (p<0.05), including C-reactive protein, α-1-antitrypsin, heterogeneous nuclear ribonucleoprotein D like, apolipoproteins A-I and A-IV in different LF clinical stages. Functional pathway analysis suggested the involvement of differentially expressed proteins in vital physiological pathways like acute phase response, hemostasis, complement and coagulation cascades. Furthermore, the differentiation between different stages of LF cases and biomarkers identified in this study clearly demonstrates the potential of the human serum profiling approach for LF detection. To our knowledge, this is the first report of comparative human serum profiling in different categories of LF patients.
Læs mere Tjek på PubMedCristine Dieter, Letícia de Almeida Brondani, Cristiane Bauermann Leitão, Fernando Gerchman, Natália Emerim Lemos, Daisy Crispim
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Cristine Dieter, Letícia de Almeida Brondani, Cristiane Bauermann Leitão, Fernando Gerchman, Natália Emerim Lemos, Daisy Crispim
Although advanced age and presence of comorbidities significantly impact the variation observed in the clinical symptoms of COVID-19, it has been suggested that genetic variants may also be involved in the disease. Thus, the aim of this study was to perform a systematic review with meta-analysis of the literature to identify genetic polymorphisms that are likely to contribute to COVID-19 pathogenesis. Pubmed, Embase and GWAS Catalog repositories were systematically searched to retrieve articles that investigated associations between polymorphisms and COVID-19. For polymorphisms analyzed in 3 or more studies, pooled OR with 95% CI were calculated using random or fixed effect models in the Stata Software. Sixty-four eligible articles were included in this review. In total, 8 polymorphisms in 7 candidate genes and 74 alleles of the HLA loci were analyzed in 3 or more studies. The HLA-A*30 and CCR5 rs333Del alleles were associated with protection against COVID-19 infection, while the APOE rs429358C allele was associated with risk for this disease. Regarding COVID-19 severity, the HLA-A*33, ACE1 Ins, and TMPRSS2 rs12329760T alleles were associated with protection against severe forms, while the HLA-B*38, HLA-C*6, and ApoE rs429358C alleles were associated with risk for severe forms of COVID-19. In conclusion, polymorphisms in the ApoE, ACE1, TMPRSS2, CCR5, and HLA loci appear to be involved in the susceptibility to and/or severity of COVID-19.
Læs mere Tjek på PubMedRobert J. Scheffler, Benjamin P. Bratton, Zemer Gitai
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Robert J. Scheffler, Benjamin P. Bratton, Zemer Gitai
Pseudomonas aeruginosa is a significant threat in healthcare settings where it deploys a wide host of virulence factors to cause disease. Many virulence-related phenotypes such as pyocyanin production, biofilm formation, and twitching motility have been implicated in causing disease in a number of hosts. In this study, we investigate these three virulence factors in a collection of 22 clinical strains isolated from blood stream infections. Despite the fact that all 22 strains caused disease and came from the same body site of different patients, they show significant variability in assays for each of the three specific phenotypes examined. There was no significant correlation between the strength of the three phenotypes across our collection, suggesting that they can be independently modulated. Furthermore, strains deficient in each of the virulence-associated phenotypes examined could be identified. To understand the genetic basis of this variability we sequenced the genomes of the 22 strains. We found that the majority of genes responsible for pyocyanin production, biofilm formation, and twitching motility were highly conserved among the strains despite their phenotypic variability, suggesting that the phenotypic variability is likely due to regulatory changes. Our findings thus demonstrate that no one lab-assayed phenotype of pyocyanin production, biofilm production, and twitching motility is necessary for a P. aeruginosa strain to cause blood stream infection and that additional factors may be needed to fully predict what strains will lead to specific human diseases.
Læs mere Tjek på PubMedRanjit Kumar Paul, Md. Yeasin, Pramod Kumar, Prabhakar Kumar, M. Balasubramanian, H. S. Roy, A. K. Paul, Ajit Gupta
PLoS One Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
by Ranjit Kumar Paul, Md. Yeasin, Pramod Kumar, Prabhakar Kumar, M. Balasubramanian, H. S. Roy, A. K. Paul, Ajit Gupta
Background Price forecasting of perishable crop like vegetables has importance implications to the farmers, traders as well as consumers. Timely and accurate forecast of the price helps the farmers switch between the alternative nearby markets to sale their produce and getting good prices. The farmers can use the information to make choices around the timing of marketing. For forecasting price of agricultural commodities, several statistical models have been applied in past but those models have their own limitations in terms of assumptions. Methods In recent times, Machine Learning (ML) techniques have been much successful in modeling time series data. Though, numerous empirical studies have shown that ML approaches outperform time series models in forecasting time series, but their application in forecasting vegetables prices in India is scared. In the present investigation, an attempt has been made to explore efficient ML algorithms e.g. Generalized Neural Network (GRNN), Support Vector Regression (SVR), Random Forest (RF) and Gradient Boosting Machine (GBM) for forecasting wholesale price of Brinjal in seventeen major markets of Odisha, India. Results An empirical comparison of the predictive accuracies of different models with that of the usual stochastic model i.e. Autoregressive integrated moving average (ARIMA) model is carried out and it is observed that ML techniques particularly GRNN performs better in most of the cases. The superiority of the models is established by means of Model Confidence Set (MCS), and other accuracy measures such as Mean Error (ME), Root Mean Square Error (RMSE), Mean Absolute Error (MAE) and Mean Absolute Prediction Error (MAPE). To this end, Diebold-Mariano test is performed to test for the significant differences in predictive accuracy of different models. Conclusions Among the machine learning techniques, GRNN performs better in all the seventeen markets as compared to other techniques. RF performs at par with GRNN in four markets. The accuracies of other techniques such as SVR, GBM and ARIMA are not up to the mark.
Læs mere Tjek på PubMedRobert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets, Jorge Flores aPATH, Center for Vaccine Innovation and Access, Seattle, Washington, USA bGrimalkin Partners, Silver Spring, Maryland, USA
Clinical Microbiology Reviews, 6.07.2022
Tilføjet 6.07.2022
Anaba, E. A., Afaya, A.
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Objective
This study assessed the correlates of late initiation and underutilisation of the WHO’s recommended eight or more antenatal care visits among women in Ghana.
Design
We analysed secondary data from 2163 women in the 2019 Ghana Malaria Indicator Survey, which collected data on malaria and antenatal care indicators among women of reproductive age across the previous 10 regions of Ghana.
Setting and participants
Women of reproductive age across the 10 regions of Ghana.
Main outcome measures
Late initiation and underutilisation of the recommended eight or more antenatal care visits among women of reproductive age.
Results
About half (49%) of the participants were between the ages of 25 and 34 years; mean (±SD)=30 (±7.10). The majority (57%) of the participants obtained less than eight antenatal care visits, while 32% initiated antenatal care visits after the first trimester. The significant factors associated with the late initiation of antenatal care visits were age, region and parity (p<0.05). Factors associated with underutilisation of the recommended eight or more antenatal care visits were marital status, wealth index, parity, region and place of residence (p<0.05).
Conclusion
A majority of the women underused antenatal care services. A significant minority of the women started antenatal care visits late. Socio-demographic factors, parity and socioeconomic factors were identified as the significant factors associated with the late initiation and underutilisation of antenatal care services. Maternal health interventions should prioritise young, multiparous and poor women.
Læs mere Tjek på PubMed
Daines, L., Mulholland, R. H., Vasileiou, E., Hammersley, V., Weatherill, D., Katikireddi, S. V., Kerr, S., Moore, E., Pesenti, E., Quint, J. K., Shah, S. A., Shi, T., Simpson, C. R., Robertson, C., Sheikh, A.
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Introduction
COVID-19 is commonly experienced as an acute illness, yet some people continue to have symptoms that persist for weeks, or months (commonly referred to as ‘long-COVID’). It remains unclear which patients are at highest risk of developing long-COVID. In this protocol, we describe plans to develop a prediction model to identify individuals at risk of developing long-COVID.
Methods and analysis
We will use the national Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) platform, a population-level linked dataset of routine electronic healthcare data from 5.4 million individuals in Scotland. We will identify potential indicators for long-COVID by identifying patterns in primary care data linked to information from out-of-hours general practitioner encounters, accident and emergency visits, hospital admissions, outpatient visits, medication prescribing/dispensing and mortality. We will investigate the potential indicators of long-COVID by performing a matched analysis between those with a positive reverse transcriptase PCR (RT-PCR) test for SARS-CoV-2 infection and two control groups: (1) individuals with at least one negative RT-PCR test and never tested positive; (2) the general population (everyone who did not test positive) of Scotland. Cluster analysis will then be used to determine the final definition of the outcome measure for long-COVID. We will then derive, internally and externally validate a prediction model to identify the epidemiological risk factors associated with long-COVID.
Ethics and dissemination
The EAVE II study has obtained approvals from the Research Ethics Committee (reference: 12/SS/0201), and the Public Benefit and Privacy Panel for Health and Social Care (reference: 1920-0279). Study findings will be published in peer-reviewed journals and presented at conferences. Understanding the predictors for long-COVID and identifying the patient groups at greatest risk of persisting symptoms will inform future treatments and preventative strategies for long-COVID.
Læs mere Tjek på PubMed
Damgaard, R. K., Jenkins, D., de Koning, M. N., Quint, W. G., Stoler, M. H., Doorbar, J., Kahlert, J., Gravitt, P. E., Steiniche, T., Petersen, L. K., Hammer, A.
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Introduction
Cervical intraepithelial neoplasia grade 2 (CIN2) represents a spectrum of lesions with variable progression and regression. Pathological diagnosis of CIN2 is subjective and poorly reproducible. Accurate diagnosis and identification of different patterns of CIN2 related to outcome are essential to reduce the risks of overtreatment or undertreatment. It is important to explore novel methods for risk stratification of CIN2 to enable targeted treatment of women at high risk of progression or persistent disease and follow-up of women at low risk. The combination of the novel biomarker human papillomavirus (HPV) E4 with p16INK4a targets steps in the transition from a productive oncogenic HPV infection (CIN1) to a transformed lesion (CIN3) within CIN2. Previous cross-sectional studies suggest that HPV E4 combined with p16INK4a may be valuable for risk assessment of CIN2. However, data on HPV E4/p16INK4a as a predictor for CIN2 regression is lacking.
Methods and analysis
We will conduct a historical cohort study including 500 women aged 23–40 years with a first CIN2 diagnosis in Aarhus, Denmark during 2000–2010. Women will be eligible if they have undergone active surveillance and have no previous record of hysterectomy, cone biopsy, and CIN2 or worse. Women will be randomly selected through the Danish Pathology Databank. Tissue samples from women included will be sectioned for p16INK4a and HPV E4 immunohistochemical staining in addition to conventional hematoxylin and eosin (H&E) staining. A positive result will be defined as HPV E4 positive. Through the Danish Pathology Databank, we will collect results on all subsequent cervical biopsies. Regression will be used as the primary outcome.
Ethics and dissemination
The study has been approved by the Ethical Committee in Central Denmark Region (1-10-72-60-20) and registered at the Faculty of Health, Aarhus University. Results will be published in a peer-reviewed journal and presented at scientific meetings.
Trial registration number
NCT05049252.
Læs mere Tjek på PubMed
Paasi, G., Ndila, C., Alaroker, F., Abeso, J., Asiimwe, G., Okello, F., Olupot-Olupot, P.
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Introduction
Blackwater fever (BWF), a complication of malaria, has in the past been considered as a rare complication of malaria in children living in high transmission settings. More recently, however, a growing number of paediatric clusters of BWF cases have been reported predominantly in sub-Saharan Africa (SSA). The aim of this study is to map evidence on BWF among children in SSA from 1 January 1960 to 31 December 2021.
Methods and analysis
This review will be guided by Arksey and O’ Malley’s methodological framework for scoping reviews with methodological refinements by Levac et al and will comply with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews’ guidelines. Five electronic databases (MEDLINE via PubMed, Embase, the Cochrane Library, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and PsycINFO) will be systematically searched using predefined keywords. In addition, reference lists of included articles will be searched. Our multidisciplinary team has formulated search strategies and two reviewers will independently complete study eligibility screening, final selection and data extraction. A third reviewer will adjudicate the final decision on disputed articles. Bibliographic data and abstract content will be collected and analysed using a data-charting tool developed iteratively by the research team.
Ethics and dissemination
This scoping review being a secondary analysis does not require ethics approval. We anticipate results of this review will broaden understanding of paediatric BWF in SSA and identify its research gaps in SSA. We will be disseminating results through journals and conferences targeting primary care providers.
Læs mere Tjek på PubMed
Jeffery, M. M., Oliveira J e Silva, L., Bellolio, F., Garovic, V. D., Dempsey, T. M., Limper, A., Cummins, N. W.
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Objectives
Evaluate the associations between patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) and their clinical outcomes after an acute viral respiratory illness (AVRI) due to COVID-19.
Design
Retrospective cohort.
Setting
The USA; 2017–2018 influenza season, 2018–2019 influenza season, and 2019–2020 influenza/COVID-19 season.
Participants
People with hypertension (HTN) taking an ACEi, ARB or other HTN medications, and experiencing AVRI.
Main outcome measures
Change in hospital admission, intensive care unit (ICU) or coronary care unit (CCU), acute respiratory distress (ARD), ARD syndrome (ARDS) and all-cause mortality, comparing COVID-19 to pre-COVID-19 influenza seasons.
Results
The cohort included 1 059 474 episodes of AVRI (653 797 filled an ACEi or ARB, and 405 677 other HTN medications). 58.6% were women and 72.9% with age ≥65. The ACEi/ARB cohort saw a larger increase in risk in the COVID-19 influenza season than the other HTN medication cohort for four out of five outcomes, with an additional 1.5 percentage point (pp) increase in risk of an inpatient stay (95% CI 1.2 to 1.9 pp) and of ICU/CCU use (95% CI 0.3 to 2.7 pp) as well as a 0.7 pp (0.1 to 1.2 pp) additional increase in risk of ARD and 0.9 pp (0.4 to 1.3 pp) additional increase in risk of ARDS. There was no statistically significant difference in the absolute risk of death (–0.2 pp, 95% CI –0.4 to 0.1 pp). However, the relative risk of death in 2019/2020 versus 2017/2018 for the ACEi/ARB group was larger (1.40 (1.36 to 1.44)) than for the other HTN medication cohort (1.24 (1.21 to 1.28)).
Conclusions
People with AVRI using ACEi/ARBs for HTN had a greater increase in poor outcomes during the COVID-19 pandemic than those using other medications to treat HTN. The small absolute magnitude of the differences likely does not support changes in clinical practice.
Læs mere Tjek på PubMed
Ratnayake, R., Peyraud, N., Ciglenecki, I., Gignoux, E., Lightowler, M., Azman, A. S., Gakima, P., Ouamba, J. P., Sagara, J. A., Ndombe, R., Mimbu, N., Ascorra, A., Epicentre and MSF CATI Working Group, Welo, P. O., Mukamba Musenga, E., Miwanda, B., Boum, Y., Checchi, F., Edmunds, W. J., Luquero, F., Porten, K., Finger, F., Alia, Assao, Bachy, D'hondt, D'Mello-Guyett, Fai, Henry-Ostian, Issa-Soumana, Malik, Mutubuki, Ntone, Panunzi, Soumana, Toure, Traore
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Introduction
Cholera outbreaks in fragile settings are prone to rapid expansion. Case-area targeted interventions (CATIs) have been proposed as a rapid and efficient response strategy to halt or substantially reduce the size of small outbreaks. CATI aims to deliver synergistic interventions (eg, water, sanitation, and hygiene interventions, vaccination, and antibiotic chemoprophylaxis) to households in a 100—250 m ‘ring’ around primary outbreak cases.
Methods and analysis
We report on a protocol for a prospective observational study of the effectiveness of CATI. Médecins Sans Frontières (MSF) plans to implement CATI in the Democratic Republic of the Congo (DRC), Cameroon, Niger and Zimbabwe. This study will run in parallel to each implementation. The primary outcome is the cumulative incidence of cholera in each CATI ring. CATI will be triggered immediately on notification of a case in a new area. As with most real-world interventions, there will be delays to response as the strategy is rolled out. We will compare the cumulative incidence among rings as a function of response delay, as a proxy for performance. Cross-sectional household surveys will measure population-based coverage. Cohort studies will measure effects on reducing incidence among household contacts and changes in antimicrobial resistance.
Ethics and dissemination
The ethics review boards of MSF and the London School of Hygiene and Tropical Medicine have approved a generic protocol. The DRC and Niger-specific versions have been approved by the respective national ethics review boards. Approvals are in process for Cameroon and Zimbabwe. The study findings will be disseminated to the networks of national cholera control actors and the Global Task Force for Cholera Control using meetings and policy briefs, to the scientific community using journal articles, and to communities via community meetings.
Læs mere Tjek på PubMed
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Lamb MJ, Smith A, Painter D, et al. Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort. BMJ Open 2021;11:e041296. doi: 10.1136/bmjopen-2020-041296
This article was previously published with an error in table 1. MGUS control numbers and percentages by gender were transposed and should read: males 11308 (51.6) and females 10620 (48.4).
Læs mere Tjek på PubMedLeiqun Xiong, Pingping Zhang, Cuibi Wang, Shen Lei, Weiyuan Chen, Xiaoying Lv, Xin Zheng
International Journal of Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
To evaluate the effect and safety of corticosteroids(CS) treatment in patients with severe fever with thrombocytopenia syndrome(SFTS).
Læs mere Tjek på PubMedCarsten Schade Larsen
International Journal of Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
Infection with SARS-CoV-2 usually causes mild to moderate respiratory disease. However, elderly patients and those with underlying chronic medical conditions are at high risk of progressing to severe COVID-19 (Ko et al., 2021, Thakur et al., 2021).
Læs mere Tjek på PubMedTawny Saleh, Tara Kerin, Trevon Fuller, Sophia Paiola, Mary C. Cambou, Yash Motwani, Caitlin N. Newhouse, Shangxin Yang, Edwin Kamau, Omai B. Garner, Sukantha Chandrasekaran, Karin Nielsen-Saines
International Journal of Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
: To characterize SARS-CoV-2 infection patterns in Los Angeles (L.A.) County youth followed at our institution during the first pandemic year.
Læs mere Tjek på PubMedMeng Wang, Qing Ji, Peng Liu, Yukun Liu
Trends in Microbiology, 6.07.2022
Tilføjet 6.07.2022
Depletion of nicotinamide adenine dinucleotide (NAD+), an important regulator of cellular energy metabolism, is a common strategy in immune-mediated cell death (ICD) in both prokaryotes and eukaryotes. Recent studies have revealed how bacteria use NAD+ depletion to protect against phages, providing insight into how eukaryotic ICD might have evolved.
Læs mere Tjek på PubMedI. Mary Poynten, Fengyi Jin, Monica Molano, Dorothy A. Machalek, Jennifer M. Roberts, Richard J. Hillman, Alyssa Cornall, Samuel Phillips, David J. Templeton, Carmella Law, Christopher K. Fairley, Andrew E. Grulich, Suzanne M. Garland, Study of Prevention of Anal Cancer Study Team
Clinical Microbiology and Infection, 6.07.2022
Tilføjet 6.07.2022
Anal cancer is preceded by high-risk human papillomavirus (HRHPV) infection, predominantly HPV16. No HPV assay is licenced for use in anal screening. We aimed to determine the sensitivity and specificity of four anal canal swab HPV assays to predict high grade squamous epithelial lesions (HSIL).
Læs mere Tjek på PubMedBurns, E., Feeley, C., Hall, P. J., Vanderlaan, J.
BMJ Open, 6.07.2022
Tilføjet 6.07.2022
Objectives
Water immersion during labour using a birth pool to achieve relaxation and pain relief during the first and possibly part of the second stage of labour is an increasingly popular care option in several countries. It is used particularly by healthy women who experience a straightforward pregnancy, labour spontaneously at term gestation and plan to give birth in a midwifery led care setting. More women are also choosing to give birth in water. There is debate about the safety of intrapartum water immersion, particularly waterbirth. We synthesised the evidence that compared the effect of water immersion during labour or waterbirth on intrapartum interventions and outcomes to standard care with no water immersion. A secondary objective was to synthesise data relating to clinical care practices and birth settings that women experience who immerse in water and women who do not.
Design
Systematic review and meta-analysis.
Data sources
A search was conducted using CINAHL, Medline, Embase, BioMed Central and PsycINFO during March 2020 and was replicated in May 2021.
Eligibility criteria for selecting studies
Primary quantitative studies published in 2000 or later, examining maternal or neonatal interventions and outcomes using the birthing pool for labour and/or birth.
Data extraction and synthesis
Full-text screening was undertaken independently against inclusion/exclusion criteria in two pairs. Risk of bias assessment included review of seven domains based on the Robbins-I Risk of Bias Tool. All outcomes were summarised using an OR and 95% CI. All calculations were conducted in Comprehensive Meta-Analysis V.3, using the inverse variance method. Results of individual studies were converted to log OR and SE for synthesis. Fixed effects models were used when I2 was less than 50%, otherwise random effects models were used. The fail-safe N estimates were calculated to determine the number of studies necessary to change the estimates. Begg’s test and Egger’s regression risk assessed risk of bias across studies. Trim-and-fill analysis was used to estimate the magnitude of effect of the bias. Meta-regression was completed when at least 10 studies provided data for an outcome.
Results
We included 36 studies in the review, (N=157 546 participants). Thirty-one studies were conducted in an obstetric unit setting (n=70 393), four studies were conducted in midwife led settings (n=61 385) and one study was a mixed setting (OU and homebirth) (n=25 768). Midwife led settings included planned home and freestanding midwifery unit (k=1), alongside midwifery units (k=1), planned homebirth (k=1), a freestanding midwifery unit and an alongside midwifery unit (k=1) and an alongside midwifery unit (k=1). For water immersion, 25 studies involved women who planned to have/had a waterbirth (n=151 742), seven involved water immersion for labour only (1901), three studies reported on water immersion during labour and waterbirth (n=3688) and one study was unclear about the timing of water immersion (n=215).
Water immersion significantly reduced use of epidural (k=7, n=10 993; OR 0.17 95% CI 0.05 to 0.56), injected opioids (k=8, n=27 391; OR 0.22 95% CI 0.13 to 0.38), episiotomy (k=15, n=36 558; OR 0.16; 95% CI 0.10 to 0.27), maternal pain (k=8, n=1200; OR 0.24 95% CI 0.12 to 0.51) and postpartum haemorrhage (k=15, n=63 891; OR 0.69 95% CI 0.51 to 0.95). There was an increase in maternal satisfaction (k=6, n=4144; OR 1.95 95% CI 1.28 to 2.96) and odds of an intact perineum (k=17, n=59 070; OR 1.48; 95% CI 1.21 to 1.79) with water immersion. Waterbirth was associated with increased odds of cord avulsion (OR 1.94 95% CI 1.30 to 2.88), although the absolute risk remained low (4.3 per 1000 vs 1.3 per 1000). There were no differences in any other identified neonatal outcomes.
Conclusions
This review endorses previous reviews showing clear benefits resulting from intrapartum water immersion for healthy women and their newborns. While most included studies were conducted in obstetric units, to enable the identification of best practice regarding water immersion, future birthing pool research should integrate factors that are known to influence intrapartum interventions and outcomes. These include maternal parity, the care model, care practices and birth setting.
PROSPERO registration number
CRD42019147001.
Læs mere Tjek på PubMed
Robert L Gottlieb, Raymund R Razonable
Lancet Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
A credit to clinical research volunteers, the global community is blessed with a panoply of pharmaceutical agents to mitigate COVID-19 in this third year of the SARS-CoV-2 pandemic. Multiple vaccines and therapeutic interventions with small molecule antivirals (ritonavir-boosted nirmatrelvir1 and remdesivir2) and macromolecular anti-spike neutralising monoclonal antibodies3–5 have reached the front lines of the war against COVID-19. The deluge of cutting-edge basic, translational, and clinical knowledge accrued in this unprecedented timespan underpin dynamically updated evidence-based guidelines.
Læs mere Tjek på PubMedGary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo-Chen Chan, Katharine J Bar, Ruanne V Barnabas, Dan H Barouch, Myron S Cohen, Christopher B Hurt, Dale R Burwen, Mary A Marovich, Bret J Musser, John D Davis, Kenneth C Turner, Adnan Mahmood, Andrea T Hooper, Jennifer D Hamilton, Janie Parrino, Danise Subramaniam, Alina Baum, Christos A Kyratsous, A Thomas DiCioccio, Neil Stahl, Ned Braunstein, George D Yancopoulos, David M Weinreich, COVID-19 Phase 3 Prevention Trial Team
Lancet Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
CAS + IMD is not authorised in any US region as of Jan 24, 2022, because data show that CAS + IMD is not active against omicron-lineage variants. In this study, done before the emergence of omicron-lineage variants, a single subcutaneous 1200 mg dose of CAS + IMD protected against COVID-19 for up to 5 months of community exposure to susceptible strains of SARS-CoV-2 in the pre-exposure prophylaxis setting, in addition to the post-exposure prophylaxis setting that was previously shown.
Læs mere Tjek på PubMedDaniele Focosi, Scott McConnell, Arturo Casadevall, Emiliano Cappello, Giulia Valdiserra, Marco Tuccori
Lancet Infectious Diseases, 6.07.2022
Tilføjet 6.07.2022
Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely used in the ongoing COVID-19 pandemic. In this paper, we review the properties of mAbs and their effect as therapeutics in the pandemic, including structural classification, outcomes in clinical trials that led to the authorisation of mAbs, and baseline and treatment-emergent immune escape. We show how the omicron (B.1.1.529) variant of concern has reset treatment strategies so far, discuss future developments that could lead to improved outcomes, and report the intrinsic limitations of using mAbs as therapeutic agents.
Læs mere Tjek på PubMedThe PLOS ONE Staff
PLoS One Infectious Diseases, 5.07.2022
Tilføjet 5.07.2022
Kirill Chmel, Aigul Klimova, Nikita Savin
PLoS One Infectious Diseases, 5.07.2022
Tilføjet 5.07.2022
Hasan Selcuk Ozger, Resul Karakus, Elif Nazli Kuscu, Umit Emin Bagriacik, Nihan Oruklu, Melek Yaman, Melda Turkoglu, Gonca Erbas, Aysegul Yucel Atak, Esin Senol
PLoS One Infectious Diseases, 5.07.2022
Tilføjet 5.07.2022
by Hasan Selcuk Ozger, Resul Karakus, Elif Nazli Kuscu, Umit Emin Bagriacik, Nihan Oruklu, Melek Yaman, Melda Turkoglu, Gonca Erbas, Aysegul Yucel Atak, Esin Senol
Læs mere Tjek på PubMedThe PLOS ONE Staff
PLoS One Infectious Diseases, 5.07.2022
Tilføjet 5.07.2022
Shubhayu Bhattacharyay, Ioan Milosevic, Lindsay Wilson, David K. Menon, Robert D. Stevens, Ewout W. Steyerberg, David W. Nelson, Ari Ercole, the CENTER-TBI investigators participants
PLoS One Infectious Diseases, 5.07.2022
Tilføjet 5.07.2022
by Shubhayu Bhattacharyay, Ioan Milosevic, Lindsay Wilson, David K. Menon, Robert D. Stevens, Ewout W. Steyerberg, David W. Nelson, Ari Ercole, the CENTER-TBI investigators participants
When a patient is admitted to the intensive care unit (ICU) after a traumatic brain injury (TBI), an early prognosis is essential for baseline risk adjustment and shared decision making. TBI outcomes are commonly categorised by the Glasgow Outcome Scale–Extended (GOSE) into eight, ordered levels of functional recovery at 6 months after injury. Existing ICU prognostic models predict binary outcomes at a certain threshold of GOSE (e.g., prediction of survival [GOSE > 1]). We aimed to develop ordinal prediction models that concurrently predict probabilities of each GOSE score. From a prospective cohort (n = 1,550, 65 centres) in the ICU stratum of the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) patient dataset, we extracted all clinical information within 24 hours of ICU admission (1,151 predictors) and 6-month GOSE scores. We analysed the effect of two design elements on ordinal model performance: (1) the baseline predictor set, ranging from a concise set of ten validated predictors to a token-embedded representation of all possible predictors, and (2) the modelling strategy, from ordinal logistic regression to multinomial deep learning. With repeated k-fold cross-validation, we found that expanding the baseline predictor set significantly improved ordinal prediction performance while increasing analytical complexity did not. Half of these gains could be achieved with the addition of eight high-impact predictors to the concise set. At best, ordinal models achieved 0.76 (95% CI: 0.74–0.77) ordinal discrimination ability (ordinal c-index) and 57% (95% CI: 54%– 60%) explanation of ordinal variation in 6-month GOSE (Somers’ Dxy). Model performance and the effect of expanding the predictor set decreased at higher GOSE thresholds, indicating the difficulty of predicting better functional outcomes shortly after ICU admission. Our results motivate the search for informative predictors that improve confidence in prognosis of higher GOSE and the development of ordinal dynamic prediction models.
Læs mere Tjek på PubMedIvan Marbaniang, Samir Joshi, Shashikala Sangle, Samir Khaire, Rahul Thakur, Amol Chavan, Nikhil Gupte, Vandana Kulkarni, Prasad Deshpande, Smita Nimkar, Vidya Mave
PLoS One Infectious Diseases, 5.07.2022
Tilføjet 5.07.2022
by Ivan Marbaniang, Samir Joshi, Shashikala Sangle, Samir Khaire, Rahul Thakur, Amol Chavan, Nikhil Gupte, Vandana Kulkarni, Prasad Deshpande, Smita Nimkar, Vidya Mave
Introduction In India, smokeless tobacco (SLT) is a predominant form of tobacco used among people living with HIV (PLHIV). Despite SLT being a risk factor for oral potentially malignant disorders (OPMDs), no prior studies have quantified the association of OPMDs with SLT use among PLHIV. This limits the planning of preventive and control strategies for oral cancer among PLHIV, who are at higher risk for the disease. Methods We enrolled 601 PLHIV and 633 HIV-uninfected individuals in an oral cancer screening study at BJ Government Medical College, Pune, India. Oral cavity images were collected using an m-Health application and reviewed by three clinicians. Participants with two clinician positive diagnoses were deemed to have suspected OPMDs. Prevalence ratios (PRs) were used to quantify the association between suspected OPMDs and SLT use among PLHIV. PRs for current SLT users, across HIV status and use duration were also estimated. Corrected PRs were obtained by modifying the maximum likelihood estimation. Models were adjusted for age, smoking, alcohol use and CD4 counts. Results Of those enrolled, 61% were men, median age was 36 years (IQR: 28–44), and 33% currently use SLT. Proportion of current SLT users was similar across PLHIV and HIV-uninfected groups but use duration for current SLT use was higher among PLHIV(p<0.05). Among PLHIV, current SLT users had a 5-times (95% CI:3.1–7.0) higher prevalence of suspected OPMDs, compared to non-users. Relative to HIV uninfected individuals with the same SLT use duration, significant associations with suspected OPMDs were seen for PLHIV with
Læs mere Tjek på PubMedAlqeer Aliyo, Abdurezak Jibril
PLoS One Infectious Diseases, 5.07.2022
Tilføjet 5.07.2022
by Alqeer Aliyo, Abdurezak Jibril
Background Anemia adversely affects children’s mental, physical and social development, particularly in Africa. In the early stages of life, it leads to severe negative consequences on the cognitive, growth and development of children. Objective This study aimed to assess anemia and associated risk factors among children under-five years old in the West Guji Zone, southern Ethiopia, from October to November 2020. Method A hospital-based quantitative cross-sectional study was conducted at Bule Hora General Hospital, Southern Ethiopia. A convenience sampling technique was used to include 375 under-five children enrolled in the study. The pretested structure questionnaire was used to collect socioeconomic and demographic characteristics of study individuals after taking appropriate written informed consent. Then, a venous blood sample was collected from each child and analyzed for hemoglobin determination using a Midray BC 3000 Plus machine. Binary logistic regression models were used to identify associated factors of anemia. A p-value ≤ 0.05 was considered statistically significant. Result The overall prevalence of anemia among under-five children was 13.2% (50) [95% CI = 5.2–21.2%]. Among anemic children under-five years of age, 12% (6) had mild anemia, 32% (16) had moderate anemia and 56% (28) had severe anemia. In this study, anemia was significantly associated with a history of intestinal protozoan infection [AOR = 2.55, 95% CI = 1.28–10.42], malaria infection [AOR = 5.01, 95% CI = 0.18–11.44] and soil-transmitted helminths infection [AOR = 6.39, 95% CI = 1.75–29.08]. Conclusion The prevalence of anemia among under-five children was found to be low in the study area; however, the majority of anemic children were in a severe stage. It could be managed by preventing malaria infection, intestinal protozoa and soil-transmitted helminthic infection.
Læs mere Tjek på PubMed